




480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





Our bioresorbable scaffold supports lumen patency during healing while avoiding a permanent implant 



 

 










Bioresorbable Drug Delivery System
480 Biomedical's novel, proprietary drug depot is ideal for localized and controlled delivery of therapeutics.

 













© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Management | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 








Management
Board of Directors
Investors









Management



Maria Palasis, Ph.D.
		President and Chief Executive Officer
Maria Palasis is President and Chief Executive Officer of 480 Biomedical. Prior to joining 480 Biomedical, Dr. Palasis was R&D director at Boston Scientific, where she managed a portfolio of external biotech and medical device investments and was responsible for the development of new convergence products. Dr. Palasis was as an early member of the team that created the TAXUS® drug-eluting stent, the single most important revenue generator for Boston Scientific at $3B/year. She held a number of positions within Boston Scientific that included strategic planning for the development of advanced combination therapies, managing alliances through clinical trials, and building and directing the company’s centralized infrastructure for the biological testing of drug eluting stent technologies. Maria received her Bachelor of Science and doctorate in chemical engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.



Robert Palladino
			Chief Financial Officer
Bob Palladino, MBA, is a Senior Executive with 35 years of global strategic and operating experience in Drug Discovery, Genomic Sequencing/Interpretation, Social Media and Registry Patient Data, Stem Cell, Medical Devices/Delivery Systems, Monitoring/Detection, Laparoscopy Procedure Systems, Gynecology, and Oncology. Bob has served as CFO for Claritas Genomics, BioNevia, Corrona, PatientsLikeMe.
Upma Sharma, Ph.D.
			Senior Director of Research and Development
Upma Sharma is Director of Research and Development. Dr. Sharma leads product development for Arsenal Medical’s novel foam-based technology platform for treatment of non-compressible hemorrhage, directing a core team through ideation and filing of intellectual property, proof of concept and pre-clinical testing, and clinical system design. Under Dr. Sharma’s scientific leadership, the company gained significant funding from DARPA/ARO for development of this hemorrhage control system. Prior to Arsenal, Dr. Sharma served as a core team member at 480 Biomedical, advancing the company’s innovative biodegradable vascular scaffold from concept to pre-clinical proof-of-concept. Dr. Sharma was responsible for materials selection and drug formulation efforts for the scaffold. Dr. Sharma earned a Ph.D. from Princeton University in Chemical Engineering and a B.S.E. with Honors from Purdue University. During a post-doctoral fellowship in Bioengineering at Rice University, Dr. Sharma was awarded a NIH Training Grant in Nanobiology. Dr. Sharma has authored 12 peer-reviewed scientific publications and is an inventor on 10 issued or pending patents.


  















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Investors | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 








Management
Board of Directors
Investors









Investors







 















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Board of Directors | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 








Management
Board of Directors
Investors









Board of Directors



Richard Mott
		Chairman
Richard Mott is currently a principal in Walkabout Consulting LLC, a management consulting and private equity firm. Mr. Mott currently consults for Warburg Pincus as an Executive in Residence.  Mr. Mott served as President and Chief Executive Officer and Director of Kyphon Inc., a NASDAQ-listed global medical device company focused on minimally invasive spinal therapies, through its acquisition by Medtronic, Inc. in late 2007. Prior to Kyphon, Mr. Mott held several executive positions, most recently as Chief Operating Officer at Wilson Greatbatch Technologies, Inc., a NYSE-listed medical technology company as well as executive operating roles within the Bristol-Myers Squibb Company.  Mr. Mott is currently Executive Chairman of the Board of Directors of Microchips Biotech, Inc., a company based on micro reservoir technology incorporating long-term implantable drug delivery technologies; Chairman of the Board of Directors of Silk Road Medical, a company which uses surgical techniques to protect the brain from stroke risk during carotid artery stenting; Executive Chairman of the Board of Directors of Relievant Medsystems, a company using therapeutic nerve ablation for the treatment of chronic low back pain; and member of the Board of Directors of Treace Medical Concepts, a company focused on foot and ankle surgical products. Mr. Mott is a Director/Owner of VFD Technologies, a private equity firm that invests in, acquires and owns manufacturing businesses with unique technical capabilities that specialize in high performance materials.


Carmichael Roberts, Ph.D.
		General Partner, North Bridge Venture Partners
		Co-Founder
Carmichael Roberts joined North Bridge Venture Partners in 2007 where he focuses mainly on early-stage companies that make products using unique chemistry and materials inventions. Prior to North Bridge, Dr. Roberts co-founded and served as the president and chief executive officer of Arsenal Medical. Dr. Roberts has co-founded other ventures, including several focused on life sciences. In 1999, Dr. Roberts was named one of the world’s top 100 young entrepreneurs by MIT’s Technology Review. Prior to his entrepreneurial career, Dr. Roberts worked in business development at GelTex Pharmaceuticals, which was acquired by Genzyme for $1.3 billion, and in new product and business development at Dow Chemical (formerly Union Carbide Corporation). Dr. Roberts received his Bachelor of Science and doctorate in organic chemistry from Duke University, and he completed his postdoctoral National Science Foundation fellowship at Harvard University. Dr. Roberts also holds a master’s degree in business administration from the MIT Sloan School of Management. He serves as an advisor for MIT’s Deshpande Center for Technological Innovation, Harvard’s Nanoscale Science and Engineering Center and the schools of Science and Engineering at Duke University.


George Whitesides, Ph.D.
		Woodford L. and Ann A. Flowers University Professor, Harvard University
		Co-Founder
Dr. Whitesides joined Harvard’s department of chemistry in 1982 and served as department chairman from 1986 to 1989. From 1963 to 1982, he was a faculty member at Massachusetts Institute of Technology. Dr. Whitesides held advisory positions on the National Research Council, National Science Foundation and the Department of Defense’s Defense Advanced Research Projects Agency (DARPA), and he is a member of the American Academy of Arts and Sciences, National Academy of Sciences, National Academy of Engineering and the American Philosophical Society, among other organizations. He has received dozens of honors, including the American Chemical Society (ACS) Award in Pure Chemistry (1975), the Arthur C. Cope Award (1995), the DARPA Award for Significant Technical Achievement (1996), the National Medal of Science (1998), the Von Hippel Award (2000), the Kyoto Prize (2003), the Dan David Award (2005), the Welch Award (2005), the Priestley Award (2007), the American Institute of Chemists Gold Medal (2007), the Prince of Asturias Foundation Award (2008), the Nanoscience Prize (2008), the Wheland Medal (2008) and the Benjamin Franklin Medal in Chemistry (2009). In addition to 480 Biomedical, George is a co-founder of a number of companies including Genzyme, GelTex, Theravance and Arsenal Medical. He received a Bachelor of Arts from Harvard University in 1960 and a doctorate from the California Institute of Technology in 1964.


Robert Langer, D.Sc.
		David H. Koch Institute Professor, Massachusetts Institute of Technology
		Co-Founder
Robert S. Langer is one of 14 Institute Professors (the highest honor awarded to a faculty member) at the Massachusetts Institute of Technology (MIT). Dr. Langer has written approximately 1,130 articles. He also has approximately 800 issued and pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed more than 250 pharmaceutical, chemical, biotechnology and medical device companies. He is the most cited engineer in history. He served as a member of the U.S. FDA’s SCIENCE Board, the agency’s highest advisory board, from 1995-2002, and as its chairman from 1999-2002. Dr. Langer has received more than 200 major awards including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers; and the 2008 Millennium Prize, the world’s largest technology prize. He is the only engineer to receive the Gairdner Foundation International Award; 76 recipients of this award have subsequently received a Nobel Prize. Among his multiple accolades, Forbes Magazine selected Dr. Langer as "one of the 15 innovators worldwide who will reinvent our future."


Maria Palasis, Ph.D.
		President and Chief Executive Officer of 480 Biomedical
Maria Palasis is President and Chief Executive Officer of 480 Biomedical. Prior to joining 480 Biomedical, Dr. Palasis was R&D director at Boston Scientific, where she managed a portfolio of external biotech and medical device investments and was responsible for the development of new convergence products. Dr. Palasis was as an early member of the team that created the TAXUS® drug-eluting stent, the single most important revenue generator for Boston Scientific at $3B/year. She held a number of positions within Boston Scientific that included strategic planning for the development of advanced combination therapies, managing alliances through clinical trials, and building and directing the company’s centralized infrastructure for the biological testing of drug eluting stent technologies. Maria received her Bachelor of Science and doctorate in chemical engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.


Terrance G. McGuire
		Co-Founder and General Partner, Polaris Venture Partners
Terry McGuire is a co-founder and general partner of Polaris Venture Partners based in the Boston office. Mr. McGuire focuses on life sciences investments. Prior to starting Polaris, Mr. McGuire spent seven years at Burr, Egan, Deleage & Co. investing in early-stage medical and information technology companies. Mr. McGuire has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.) and MicroCHIPS. Mr. McGuire represents Polaris on the boards of directors of Acceleron Pharma, Adimab, Arsenal Medical, deCODE Genetics, Ironwood Pharmaceuticals, Life Line Screening, MicroCHIPS, Pulmatrix, SustainX Energy Storage Solutions and Trevena. He has also served on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, GlycoFi, Transform Pharmaceuticals and Remon Medical Technologies. Mr. McGuire is chairman emeritus of the National Venture Capital Association. He chairs the board of overseers of the Thayer School of Engineering at Dartmouth College, and serves on the boards of MIT’s David Koch Institute for Integrative Cancer Research and the Arthur Rock Center for Entrepreneurship at Harvard Business School. Mr. McGuire holds a master’s degree in business administration from Harvard Business School, a Master of Science in engineering from The Thayer School at Dartmouth College and a Bachelor of Science in physics and economics from Hobart College. Mr. McGuire is a recipient of the 2009 Massachusetts Society for Medical Research Award and the 2005 Albert Einstein Award for Outstanding Achievement in the Life Sciences.


Guido Neels
		Managing Director, EW Healthcare Partners
Guido Neels served as chief operating officer of Guidant Corporation, a world leader in the development of cardiovascular medical products, from May 2004 until his retirement in November 2005. Mr. Neels was responsible for the global operations of Guidant's four operating units: Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery and Endovascular Solutions. From December 2002 to May 2004, he was group chairman, office of the president at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. From January 2000 to December 2002, he was president of Guidant for Europe, Middle East, Africa and Canada. He previously served as vice president of global marketing for Vascular Intervention and as managing director for German and Central European operations. From 1982 to 1994, until Guidant was spun off as an independent public company from Eli Lilly and Co., Mr. Neels held various general management and sales and marketing positions at Lilly in the U.S. and Europe.


Dennis Dougherty
		Intersouth Partners
Since founding Intersouth in 1985, Dennis Dougherty has been active in all aspects of the venture investment process. He has served on dozens of boards of directors for both private and public companies. He is known for his experienced insight, consensus building and syndicate leadership.
Dennis has invested in and worked with portfolio companies through several economic cycles and has served as interim CEO when necessary.  He has long been active in the venture industry having served on the board of directors of the National Venture Capital Association, on the Steering Committee for the Kauffman Fellows Program and as a mentor for two classes of Kauffman Fellows. He also served on the Board of the NC State University Seed Fund and the Governor’s Biotechnology Steering Committee. He was a founder of the highly successful Council for Entrepreneurial Development (CED) and the Chair of its first Venture Conference.   In 2005, Mr. Dougherty was named the Ernst & Young Entrepreneur of the Year for the Carolinas.
Prior to founding Intersouth, Mr. Dougherty was an office managing partner and head of the high growth business practice for Touche Ross & Co. Before entering finance and accounting, he was in sales and marketing for petrochemicals and polymers.   He holds a B.A. from Oklahoma City University, where he was named Distinguished Alumnus of the Year, and where he served on the Board of Trustees for 8 years.


Tony Semedo
		Vice President and General Manager, Medtronic
		Endovascular Therapies
Tony Semedo is vice president and general manager of endovascular and peripheral therapies for Medtronic. In his current role he has global responsibility for strategic direction and day to day operations for the endovascular innovations business. Mr. Semedo joined Medtronic in 2002, as vice president of R&D for Medtronic [AVE] Vascular for the coronary, peripheral and endovascular businesses. In 2005, Mr. Semedo moved to Japan as the co-business leader for the Medtronic Japan cardiovascular business, which includes the coronary and peripheral, endovascular, structural heart disease and revascularization and surgical technologies businesses. Prior to joining Medtronic, Mr. Semedo held various management and leadership positions with Alaris Medical Systems and Eli Lilly & Co. He began his career with Abbott Laboratories as a product development engineer. Mr. Semedo holds a Bachelor’s degree in plastics engineering from the University of Massachusetts.

 
 















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Careers | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 








Job Opportunities









Careers


480 Biomedical uses materials engineering to bring life-changing therapies to patients. Our multi-disciplinary team of biologists, chemists, materials scientists, engineers and business professionals work in close collaboration to understand the biology of disease and to create solutions that address some of today’s most challenging and critical unmet clinical needs.
If you are a highly self-motivated problem-solver, comfortable working as part of a cross-functional, interdisciplinary team, and look to work in an extremely dynamic and fast-paced environment, then you may be just who we’re looking for. We are always on the lookout for technical and business professionals who are eager to have a significant impact on improving patient care.
480 Biomedical is an equal-opportunity employer, offering competitive cash and stock-based compensation, excellent employee benefits and tremendous opportunity for personal and professional growth in an outstanding and intellectually-challenging work environment.
Contact us at careers@480biomedical.com to submit your resume.
Click here for Job Opportunities 















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Technology | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 











Our Technology


The 480 Biomedical scaffold technology combines biocompatible materials with innovative engineering for the optimal balance of drug delivery, radial force, flexibility and bioresorbability. Our proprietary drug depot is ideal for controlled delivery of therapeutics. 















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Contact Us | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 










   

 







Contact Us



	Click for Google map
480 Biomedical
	480 Arsenal Street
	Watertown, MA 02472
617.393.4600
Directions to 480 Biomedical
480 Biomedical is located in Watertown, five miles west of downtown Boston.
Please click on the map at the right for customized directions.
480 Arsenal Street is located in a business park one block north of Arsenal Street.
From Arsenal Street, turn into the entrance to the complex at the light.
After you cross the walk/bike path, bear right, then turn left into the first driveway – you’ll see an enormous satellite dish in front of the building.
480 Biomedical is located on the second floor at the top of the stairs. 















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




















Products | 480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





 

 











Products


















© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us






















 






480 Biomedical, Inc. | Government Contractor







 








 






  dytyetrzurfdybtyeeytdwdyuadebwedrvv






					Government Contracts				

					Federal Agencies				



				More 





 Search






							Government Contractors							×














 
















Menu


See All Government Contractors
OverviewContractsCategoriesProducts/ServicesPlace of PerformanceVendor Details 








					480 Biomedical, Inc.				


OverviewContractsCategoriesProducts/ServicesMorePlace of PerformanceVendor Details 








480 Biomedical, Inc.



Overview




Contracts




Categories




Products/Services




Place of Performance




Vendor Details




References










 See all Government Contractors				

 Research Guide				




Share
















480 Biomedical, Inc. Government Contractor in Watertown, MA

 






dollars obligated (Latest year)$397,952 United States Dollarslatest fiscal year2016total dollars obligated (Since FY2007)$13,605,153 United States Dollarsnumber of contracts (Since FY2007)3 

 

See all Contracts for this Company See all Government Contractors 












Advertisement


ShareOverviewSummary480 Biomedical, Inc. has worked on three contracts worth $13.6 million USD in obligations from the federal government since FY2007. In its latest active fiscal year (2016), the organization received a total of $397,952 USD in obligations.The principal agencies it has contracted with are the Department of Defense and Department of Health and Human Services.

Principal Agencies
Department of DefenseDepartment of Health and Human Services


Principal Category (NAICS)
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)


Principal Product or Service (PSC)
Research and Development - Applied Research/Exploratory Development (AZ12)


Designations
Small Business, For Profit Organization, and Non-Tax Exempt Corporate Entity


Organization Type
Corporate Not Tax Exempt


Website
480biomedical.com 
Contact

Phone Number
(617) 393-4600
Location
How does 480 Biomedical, Inc. compare to other vendors?A comparison of the amount of contract awards obligated to 480 Biomedical, Inc. since FY2007 with other vendors in its location.Awarded far higher than average compared to  76 vendors in Zip Code 02472, MA.Awarded far higher than average compared to  1,259 vendors in Congressional District 5, MA.Awarded far higher than average compared to  11,234 vendors in Massachusetts.Awarded far higher than average compared to all  494,388 federal vendors.


Comparison

Vendor NameTotal Dollars Obligated (Since FY2007)ZipcodeIDIDColor480 Biomedical, Inc.$13.6 million USDZip Code 02472, MAZip Code 02472, MA Federal Contractors$122,916 USDCongressional District 5, MA Federal Contractors$99,205 USDMassachusetts Federal Contractors$44,942.50 USDAll Federal Contractors$36,884 USD




ZipCongressional DistrictStateMoreZip



See all vendors from Zip Code 02472, MA ›Congressional District



See all vendors from Congressional District 5, MA ›State



See all vendors from Massachusetts ›
 





Advertisement


ShareContractsBy Year

The federal government obligated 480 Biomedical, Inc. a high of $4.62 million USD in FY2012 and low of $200,000 USD in FY2013. On average, it received $1,005,900 United States Dollars in contract obligations per fiscal year.* Dollars Obligated: The amount of money obligated towards a vendor by a federal agency or agencies to work on a contract.* Base and All Options (Ceiling): The maximum amount that can be awarded to a contract as mutually agreed upon by the vendor and agency.



Fiscal YearTotal Dollars ObligatedTotal Base & All Options (Ceiling)ID20124,620,0264,620,02620104,094,0046,868,81520112,774,811020141,005,9001,005,9002015512,460512,4602016397,952397,9522013200,000200,000

By Date Signed



Contract SearchContracts that 480 Biomedical, Inc. signed from FY2007 onwards.Most Recent

ContractContract DescriptionProduct or Service (PSC)Signed DateCompletion DateAgencyDollars ObligatedPercent ObligatedIDVendor NameHHSN268201600041CType: Definitive Contract (1 year)SBIR TOPICDEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA IN NEONATES CAN# 16-8470256Biomedical - Applied Research/Exploratory Development (AN12)9/15/169/26/17Department of Health and Human Services$397,952 USD100% obligatedHHSN268201300063CType: Definitive Contract (2 years)SBIR TOPIC 079 PHASE I- BIOABSORBABLE STENTS FOR PEDIATRIC PULMONARY ARTERY STENOSIS AND AORTIC COARCTATIONBiomedical - Applied Research/Exploratory Development (AN12)9/27/133/26/16Department of Health and Human Services$1,718,360 USD100% obligatedW911NF10C0089Type: Definitive Contract (3 years)RESEARCH CONTRACT AWARD PROPOSAL TITLED "SELF-EXPANDING, TOUGH BIODEGRADABLE ELASTOMERS FOR WOUND STASIS."Research and Development - Applied Research/Exploratory Development (AZ12)6/29/103/31/14Department of Defense$11,488,800 USD100% obligated

See all contracts for this vendor ›Related VendorsVendors with the same primary NAICS and PSC categorizations.

Title FieldTotal Dollars Obligated (Since FY2007)IDVendor NameGeorgia Tech Research Corporation in Atlanta, GA Contracts$603 million USDMantech Tsg-2 Joint Venture in Fairfax, VA Contracts$100 million USDCamgian Microsystems Corporation in Starkville, MS Contracts$22.8 million USDQuanterion Solutions Inc in Utica, NY Contracts$33.5 million USDGxm Consulting Llc in Ashburn, VA Contracts$40.1 million USDXl Scientific, Llc in Albuquerque, NM Contracts$12.2 million USDDe Technologies, Inc. in King Of Prussia, PA Contracts$51.6 million USDBlock Mems, Llc in Marlborough, MA Contracts$20 million USDBridger Photonics, Inc. in Bozeman, MT Contracts$14.3 million USDCreative Digital Systems Integration, Inc. in Simi Valley, CA Contracts$6.31 million USD

Help us Improve!




Submit






Submit

 





Advertisement


ShareCategories ProcuredWhen the Federal government intends to acquire goods or services, it identifies the NAICS code that describes the principal purpose of that procurement. NAICS is production oriented (not product oriented) and categorizes businesses with others that have similar methods of production.Since FY2007, 480 Biomedical, Inc. has been engaged in procurements with the following NAICS codes:





Category (NAICS)Total Dollars ObligatedIDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)13,207,201Research and Development in Biotechnology - except nanobiotechnologies research and experimental development laboratories  (541711)397,952

DestinationThe dollars obligated to 480 Biomedical, Inc. to fulfill procurements by NAICS category, along with the federal agencies that procured them. Hover over the visualization for more detail.





Category (NAICS)Total Dollars ObligatedIDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)11,488,841Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)1,718,360Research and Development in Biotechnology - except nanobiotechnologies research and experimental development laboratories  (541711)397,952

Comparison



Vendor NameDollars Obligated (Latest Year)IDIDColor480 Biomedical, Inc.$397,952 USDAll Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712) Vendors in Massachusetts$103,986 USDAll Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712) Vendors$98,988 USD




Higher Than AverageThe principal NAICS category of 480 Biomedical, Inc. is Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712) as measured by the total amount obligated in contract awards to the vendor since FY2007.In its latest full year of contract work (FY2016), 480 Biomedical, Inc. was obligated a total of $397,952, an amount that was 283% more than the average vendor from Massachusetts specializing in Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories and 4 times more than all vendors in the U.S. classified by this NAICS category.
Other Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories Vendors in Massachusetts

Vendor NameLocationDollars Obligated (Latest Year)Principal Category (NAICS)Principal Product or Service (PSC)Latest Fiscal YearIDStateOdyssey Systems Consulting Group, Ltd.Wakefield, MA$143 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Contract, Procurement and Acquisition Support Services (R707)2016Oasis Systems, LlcLexington, MA$120 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Contract, Procurement and Acquisition Support Services (R707)2016Sumaria Systems, Inc.Danvers, MA$71.6 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Professional Services (R499)2016Systems & Technology Research LlcWoburn, MA$45.3 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Applied Research/Exploratory Development (AD92)2016Physical Sciences Inc.Andover, MA$37 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Applied Research/Exploratory Development (AD92)2016Charles River Analytics, Inc.Cambridge, MA$36 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Applied Research/Exploratory Development (AD92)2016Aptima, Inc.Woburn, MA$32.4 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Basic Research (AZ11)2016Mercury Systems, Inc.Chelmsford, MA$29.4 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Electronic Countermeasures, Counter-Countermeasures and Quick Reaction Capability Equipment (5865)2016President And Fellows Of Harvard CollegeCambridge, MA$24.4 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Space Science and Applications - Basic Research (AR21)2016Scientific Systems Company Inc.Woburn, MA$20.7 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Applied Research/Exploratory Development (AD92)2016Woods Hole Oceanographic InstitutionWoods Hole, MA$17.3 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Space Science and Applications - Basic Research (AR21)2016Tiax LlcLexington, MA$12.8 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Engineering and Technical Services (R425)2016Partners Healthcare System, Inc.Boston, MA$12.2 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Biomedical - Applied Research/Exploratory Development (AN12)2016Triton Systems, Inc.Chelmsford, MA$10.3 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense Electronics and Communication Equipment - Applied Research/Exploratory Development (AC62)2016Lyric Semiconductor, Inc.dytyetrzurfdybtyeeytdwdyuadebwedrvvCambridge, MA$7.32 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Advanced Development (AD93)2011New England Research Institutes, Inc.Watertown, MA$6.12 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Biomedical - Applied Research/Exploratory Development (AN12)2016Transmural Systems LlcAndover, MA$6 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Biomedical - Applied Research/Exploratory Development (AN12)2016Busek Co., Inc.Natick, MA$5.99 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Aeronautics and Space Technology - Basic Research (AR11)2016Spectral Sciences, Inc.Burlington, MA$5.77 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense Missile and Space Systems - Basic Research (AC21)2016Ocean Acoustical Services And Instrumentation Systems IncLexington, MA$5.68 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense - Advanced Development (AD93)2016Mide Technology CorporationMedford, MA$5.32 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Engineering and Technical Services (R425)2016Eo Vista, LlcActon, MA$4.96 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Basic Research (AZ11)2016Diversified Technologies, Inc.Bedford, MA$4.91 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Defense Ships - Applied Research/Exploratory Development (AC32)2016Block Mems, LlcMarlborough, MA$4.61 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Continuus Pharmaceuticals, Inc.Woburn, MA$4.4 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Basic Research (AZ11)2016

See all Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712) Vendors in Massachusetts › 

 


InsideGov is a government research site that uses Graphiq’s semantic technology to deliver deep insights via data-driven articles, visualizations and research tools.


										Deep insights from government data. Knowledge delivered. ›
									









ShareProducts/Services ProcuredProduct Service Codes (PSC) describe products, services, and research and development (R&D) purchased by the federal government. These codes indicate what was bought for each contract action reported in the Federal Procurement Data System (FPDS).Since FY2007, 480 Biomedical, Inc. has been engaged in procurements categorized by the following PSCs:





Product or ServiceTotal Dollars ObligatedIDResearch and Development - Applied Research/Exploratory Development (AZ12)11,488,841Biomedical - Applied Research/Exploratory Development (AN12)2,116,312

DestinationThe dollars obligated to 480 Biomedical, Inc. to fulfill procurements by PSC, along with the federal agencies that procured them. Hover over the visualization for more detail.





Product or ServiceTotal Dollars ObligatedIDResearch and Development - Applied Research/Exploratory Development (AZ12)11,488,841Biomedical - Applied Research/Exploratory Development (AN12)2,116,312

Comparison



Vendor NameDollars Obligated (Latest Year)IDIDColor480 Biomedical, Inc.$397,952 USDAll Research and Development - Applied Research/Exploratory Development (AZ12) Vendors in Massachusetts$169,445 USDAll Research and Development - Applied Research/Exploratory Development (AZ12) Vendors$100,000 USD




Higher Than AverageThe principal Product or Service Code (PSC) of 480 Biomedical, Inc. is Research and Development - Applied Research/Exploratory Development (AZ12) as measured by the total amount obligated in contract awards to the vendor since FY2007.In its latest full year of contract work (FY2016), 480 Biomedical, Inc. was obligated a total of $397,952, an amount that was 135% more than the average vendor from Massachusetts specializing in Research and Development - Applied Research/Exploratory Development and 298% more than all vendors in the U.S. classified by this PSC.
Other Research and Development - Applied Research/Exploratory Development Vendors in Massachusetts

Vendor NameLocationDollars Obligated (Latest Year)Principal Category (NAICS)Principal Product or Service (PSC)Latest Fiscal YearIDStateSeven Bridges Genomics Inc.dytyetrzurfdybtyeeytdwdyuadebwedrvvCambridge, MA$5.73 million USDData Processing, Hosting, and Related Services (518210)Research and Development - Applied Research/Exploratory Development (AZ12)2016Block Mems, LlcMarlborough, MA$4.61 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Premium Power CorporationWoburn, MA$1.89 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2011Migma Systems, IncWalpole, MA$1.5 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Akita Innovations LlcNorth Billerica, MA$1.01 million USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Winchester Technologies, LlcWinchester, MA$570,439 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Enevolv, Inc.Cambridge, MA$554,999 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Aarno Labs LlcCambridge, MA$499,723 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Sofar Acoustics, LlcWoburn, MA$454,844 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Arsenal Medical, Inc.Watertown, MA$406,397 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Eye-R Systems, Inc.Boston, MA$404,577 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2014480 Biomedical, Inc.Watertown, MA$397,952 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Nutonomy IncCambridge, MA$373,673 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Camx Power LlcLexington, MA$339,460 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Special Projects Team, LlcSouth Deerfield, MA$300,000 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2011Signablok, Inc.Worcester, MA$149,950 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2012Sensimetrics CorporationMalden, MA$140,346 USDResearch and Development in the Social Sciences and Humanities (541720)Research and Development - Applied Research/Exploratory Development (AZ12)2015Ca Goudey & AssociatesNewburyport, MA$120,000 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Nek Associates, Ltd.Allston, MA$107,975 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2011Boxboro Systems LLCBoxborough, MA$100,000 USDInstruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables (334513)Research and Development - Applied Research/Exploratory Development (AZ12)2008Larry Hill Consulting, Inc.North Eastham, MA$99,813 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2009Bodkin Design & Engineering LlcNewton, MA$70,000 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2016Nanobiosym, IncCambridge, MA$50,000 USDResearch and Development in the Physical, Engineering, and Life Sciences (541710)Research and Development - Applied Research/Exploratory Development (AZ12)2009Riptide Autonomous Solutions LlcPembroke, MA$43,367 USDResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) - except nanotechnology research and experimental development laboratories (541712)Research and Development - Applied Research/Exploratory Development (AZ12)2015Advanced Environmental Modeling ServiceDartmouth, MA$20,000 USDResearch and Development in the Physical, Engineering, and Life Sciences (541710)Research and Development - Applied Research/Exploratory Development (AZ12)2007

See all Research and Development - Applied Research/Exploratory Development (AZ12) Vendors in Massachusetts › 





Advertisement


SharePlace of Performance
The locations of the principal plant or place of business where 480 Biomedical, Inc. in Watertown, MA has had their items produced, supplied from stock, or services performed since FY2007.


ZipCongressional DistrictStateMoreZip



Congressional District



State






ZipcodeZip Code 02472, MACongressional DistrictsCongressional District 7, MA and Congressional District 5, MAStateMassachusetts
 

 







ShareVendor DetailsVisit the full company profile of 480 Biomedical, Inc..

Key FactsFundingInvestorsInvestors - TypeInvestors - CompositionInvestors - GeoInvestors - Geo CompositionTransactionsTeamMoreKey Facts

Status
Private - Expansion-stage


Industry
Medical Devices & Instruments


Location
Watertown, MA


Funding Summary
$38.9M in 4 rounds from 5 investors


Last Funded
November 29, 2016
Funding

Funding AmountTransaction DateTotal Cumulative FundingProceeds PurposesIDCompany Name$6 million USDNovember 29, 2016$38.9 million USDVenture EquityProceeds:" 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing." - SEC FilingInvestors:Undisclosed Investor (Undisclosed)$1.2 million USDJune 18, 2015$32.9 million USDSeries CProceeds:"The Broadview funds will support the development of a bioresorbable scaffold to treat children with pulmonary artery stenosis (PAS), a narrowing in the branches of the pulmonary artery that reduces blood flow to the lungs and can lead to heart failure." - SEC FilingInvestors:Broadview Ventures (Boston, MA)$10.5 million USDJune 3, 2015$31.7 million USDVenture EquityInvestors:Intersouth Partners (Durham, NC)North Bridge Venture Partners (San Mateo, CA)Polaris Partners (Waltham, MA)$21.2 million USDMarch 31, 2013$21.2 million USDVenture EquityInvestors:Intersouth Partners (Durham, NC)Polaris Partners (Waltham, MA)Undisclosed Investor

Investors

Investment FirmRounds ParticipatedSummary of Rounds ParticipatedIDCompanyPolaris Partners2Venture Equity ($21,200,000), Venture Equity ($10,500,000)Undisclosed Investor2Venture Equity ($21,200,000), Venture Equity ($5,999,999)Intersouth Partners2Venture Equity ($21,200,000), Venture Equity ($10,500,000)Broadview Ventures1Series C ($1,200,000)North Bridge Venture Partners1Venture Equity ($10,500,000)

Investors - TypeCumulative Unique Investors in 480 Biomedical

Transaction YearTotal InvestorsVenture Capital InvestorsAnnotationIDCompany Name201555Venture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed201655Venture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed201755Venture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed201333Venture Capital Investors:Intersouth PartnersPolaris PartnersUndisclosed201433Venture Capital Investors:Intersouth PartnersPolaris PartnersUndisclosed

Investors - CompositionCumulative Composition of 480 Biomedical's Investors

Transaction YearVenture Capital InvestorsAnnotationIDCompany Name2013100 percentVenture Capital Investors:Intersouth PartnersPolaris PartnersUndisclosed2014100 percentVenture Capital Investors:Intersouth PartnersPolaris PartnersUndisclosed2015100 percentVenture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed2016100 percentVenture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed2017100 percentVenture Capital Investors:Broadview VenturesNorth Bridge Venture PartnersIntersouth PartnersPolaris PartnersUndisclosed

Investors - GeoInvestors by Location (Cumulative)

Transaction YearAnnotation GeoCalifornia InvestorsMassachusetts InvestorsNorth Carolina InvestorsUS Investors (State Unknown)IDCompany Name2013US Investors (State Unknown):UndisclosedMassachusetts Investors:Polaris PartnersNorth Carolina Investors:Intersouth Partners1112014US Investors (State Unknown):UndisclosedMassachusetts Investors:Polaris PartnersNorth Carolina Investors:Intersouth Partners1112015US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners12112016US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners12112017US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners1211

Investors - Geo CompositionGeographic Composition of Investors (Cumulative)

Transaction YearAnnotation GeoCalifornia InvestorsMassachusetts InvestorsNorth Carolina InvestorsUS Investors (State Unknown)IDCompany Name2013US Investors (State Unknown):UndisclosedMassachusetts Investors:Polaris PartnersNorth Carolina Investors:Intersouth Partners33.3 percent33.3 percent33.3 percent2014US Investors (State Unknown):UndisclosedMassachusetts Investors:Polaris PartnersNorth Carolina Investors:Intersouth Partners33.3 percent33.3 percent33.3 percent2015US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners20 percent40 percent20 percent20 percent2016US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners20 percent40 percent20 percent20 percent2017US Investors (State Unknown):UndisclosedCalifornia Investors:North Bridge Venture PartnersMassachusetts Investors:Broadview VenturesPolaris PartnersNorth Carolina Investors:Intersouth Partners20 percent40 percent20 percent20 percent

Transactions

Round SummaryInvestment FirmTypeDateIDCompany NameVenture Equity ($5,999,999)Undisclosed InvestorVenture Capital11/29/2016Series C ($1,200,000)Broadview VenturesVenture Capital06/18/2015Venture Equity ($10,500,000)Polaris PartnersVenture Capital06/03/2015Venture Equity ($10,500,000)North Bridge Venture PartnersVenture Capital06/03/2015Venture Equity ($10,500,000)Intersouth PartnersVenture Capital06/03/2015Venture Equity ($21,200,000)Polaris PartnersVenture Capital03/31/2013Venture Equity ($21,200,000)Intersouth PartnersVenture Capital03/31/2013Venture Equity ($21,200,000)UndisclosedVenture Capital03/31/2013

Team

NameTitleIDMaria PalasisChief Executive OfficerScott PittChief Financial Officer



 





Advertisement





×






References




Sources: USASpending.gov, VentureDeal, Rob J Hyndman, D&B, Localeze, and SEC. Show details  Hide details  







Was this page helpful?

Yes
No


 

BlkHol Email


Welcome to 
Hi! We see you would like to submit a rating. Please login or create an account to do so. Thank you!


Sign In With




Login with Google




Login with Facebook
 We'll never post without your permission.



Don't have an account?
Sign Up Now




Privacy
Terms & Conditions









						© 2017 Graphiq Inc. All Rights Reserved.
						
Support
Terms
Privacy
Ad Choices and Cookie Policy










 
 




 







480 Biomedical Sinus Drug Depot - Full Text View - ClinicalTrials.gov



































 Skip to Main Content 


This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more 

We will be updating this site in phases. This allows us to move faster and to deliver better services.
		Show less 


 

IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study.  Read more...



IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...

 
A service of the U.S. National Institutes of Health




 

×

Find Studies

New Search
Advanced Search
See Studies by Topic
See Studies on Map
How to Search
How to Use Search Results
How to Find Results of Studies
How to Read a Study Record


About Studies

Learn About Studies
Other Sites About Studies
Glossary of Common Site Terms


Submit Studies

Why Should I Register and Submit Results?
FDAAA 801 Requirements
How to Apply for an Account
How to Register Your Study
How to Edit Your Study Record
How to Submit Your Results
Frequently Asked Questions
Support Materials
Training Materials


Resources

Selected Publications
Clinical Alerts and Advisories
RSS Feeds
Trends, Charts, and Maps
Downloading Content for Analysis


About Site

ClinicalTrials.gov Background
About the Results Database
History, Policies, and Laws
Media/Press Resources
Linking to This Site
Terms and Conditions
Disclaimer






 
Saved Studies

Saved Studies (0)


Give us feedback



Find Studies

New Search
Advanced Search
See Studies by Topic
See Studies on Map
How to Search
How to Use Search Results
How to Find Results of Studies
How to Read a Study Record


About Studies

Learn About Studies
Other Sites About Studies
Glossary of Common Site Terms


Submit Studies

Why Should I Register and Submit Results?
FDAAA 801 Requirements
How to Apply for an Account
How to Register Your Study
How to Edit Your Study Record
How to Submit Your Results
Frequently Asked Questions
Support Materials
Training Materials


Resources

Selected Publications
Clinical Alerts and Advisories
RSS Feeds
Trends, Charts, and Maps
Downloading Content for Analysis


About Site

ClinicalTrials.gov Background
About the Results Database
History, Policies, and Laws
Media/Press Resources
Linking to This Site
Terms and Conditions
Disclaimer










Home
Study Record Detail



480 Biomedical Sinus Drug Depot


      This study is currently recruiting participants.
                  
See 
 Contacts and Locations



Verified June 2017 by 480 Biomedical, Inc.
    
Sponsor:
 480 Biomedical, Inc. 
Information provided by (Responsible Party):
480 Biomedical, Inc.


ClinicalTrials.gov Identifier:
NCT02967731
First received: November 14, 2016
Last updated:  June 8, 2017
Last verified:  June 2017 
 History of Changes 



Full Text View     
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

  


  Purpose

This is a Phase I, exploratory safety study of the 480 Biomedical Mometasone Furoate Sinus Drug Depot in adult subjects with chronic sinusitis.





Condition


Intervention


Phase




Chronic Sinusitis


Drug: 480 Mometasone Furoate Sinus Drug Depot


Phase 1













Study Type:

        Interventional
                      


Study Design:
Intervention Model: Single Group AssignmentMasking: No maskingPrimary Purpose: Treatment


Official Title:
An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis




Resource links provided by NLM:




MedlinePlus related topics:
            Sinusitis



Drug Information available for:
            Mometasone furoate
Mometasone furoate monohydrate

U.S. FDA Resources




Further study details as provided by 480 Biomedical, Inc.:



Primary Outcome Measures:
      
Product related serious adverse events from baseline visit to 4 weeks post procedure [ Time Frame: 4 weeks post procedure ]




Secondary Outcome Measures:
      
Plasma Mometasone Furoate concentration level from pre-treatment to end of treatment [ Time Frame: Up to 24 weeks ]











 Estimated  Enrollment:
20


  Actual  Study Start Date:
June 6, 2017


  Estimated  Study Completion Date:
June 2018


  Estimated  Primary Completion Date:
February 2018 (Final data collection date for primary outcome measure)








             Arms           



            Assigned Interventions
          




          Experimental: 480 Mometasone Furoate Sinus Drug Depot
480 Mometasone Furoate Sinus Drug Depot


                      Drug: 480 Mometasone Furoate Sinus Drug Depot
Management of Chronic Sinusitis











  Eligibility










Ages Eligible for Study:   
18 Years and older   (Adult, Senior)


Sexes Eligible for Study:   
All


Accepts Healthy Volunteers:   
No


Criteria
Inclusion Criteria:

Diagnosis of CS.
Female study subjects of child-bearing potential must have a negative pregnancy test and must agree to not become pregnant during the course of the study.
The study subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent as approved by the ethics committee of the respective clinical site.
The study subject agrees to comply with all study requirements

Exclusion Criteria:

Known history of intolerance to corticosteroids.
Oral-steroid dependent condition.
Having had corticosteroids with potential systemic effect (e.g., oral, parenteral, or high dose topical) 1 month prior to screening visit.
Subjects with acute or chronic intracranial or orbital complications of chronic rhinosinusitis (e.g., brain abscess, related problems with eyes or central nervous system).
Known history of hypothalamic pituitary adrenal (HPA) axial dysfunction or having morning serum cortisol level at screening outside of normal range.
Previous pituitary or adrenal surgery.
History or diagnosis (in either eye) of glaucoma, ocular hypertension, or cataracts.
Recent participation in another clinical trial within 1 month of screening visit.
Subjects currently participating in an investigational drug or device study.






  Contacts and Locations


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. 
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. 
For general information, see Learn About Clinical Studies.


    Please refer to this study by its ClinicalTrials.gov identifier: NCT02967731


Contacts











Contact: Veronica Faughnan
617-393-4600
vfaughnan@480biomedical.com







Locations








Australia

The Queen Elizabeth Hospital
Recruiting

Adelaide, Australia  

Royal Brisbane and Women's Hospital
Recruiting

Brisbane, Australia  

Monash Medical Center
Recruiting

Melbourne, Australia  
New Zealand

University of Auckland
Recruiting

Auckland, New Zealand  



Sponsors and Collaborators
480 Biomedical, Inc.







  More Information














Responsible Party:
480 Biomedical, Inc.


ClinicalTrials.gov Identifier:

NCT02967731    
        History of Changes



Other Study ID Numbers:

                                    480MFSDD2016-001 



Study First Received:
November 14, 2016


Last Updated:
June 8, 2017











Studies a U.S. FDA-regulated Drug Product:
No


Studies a U.S. FDA-regulated Device Product:
No






  Additional relevant MeSH terms:
  









                    Sinusitis
                    Chronic Disease
                    Paranasal Sinus Diseases
                    Nose Diseases
                    Respiratory Tract Diseases
                    Respiratory Tract Infections
                    Otorhinolaryngologic Diseases


                    Disease Attributes
                    Pathologic Processes
                    Mometasone Furoate
                    Anti-Inflammatory Agents
                    Dermatologic Agents
                    Anti-Allergic Agents





ClinicalTrials.gov processed this record on July 24, 2017



To Top




For Patients and Families
For Researchers
For Study Record Managers




Home
RSS Feeds
Site Map
Terms and Conditions
Disclaimer
Customer Support





Copyright
Privacy
Accessibility
Viewers and Players
Freedom of Information Act
USA.gov


U.S. National Library of Medicine
U.S. National Institutes of Health

            U.S. Department of Health and Human Services







	480 Biomedical Inc. - Company Profile - BioCentury




























































Publications
archives
BCIQ
Conferences
version 4.3.15.600





Free Trial / Subscribe


SIGN IN



English
简体中文
日本語
한국어







Biocentury





Menu





                                        Home
                                        
+




                                        Publications
                                        
+



Publications Home >


BioCentury>


BC Innovations>


BC Extra>


BC Week In Review>


Current Issues>




Archives 
                                        
+



Archives Home >


Basic Search>


Advanced Search>


Back Issues>




BCIQ
                                        
+



BCIQ Home >


Overview>


Pipeline Analyst>


Financial Analyst>


Company Analyst>


Deal Analyst>




Conferences 
                                        
+




Conferences Home >


Newsmakers


Bio€quity Europe


Future Leaders


China Healthcare Summit


Other Industry Events





eLearning 
                                        
+



eLearning Home >


Videos>


White Papers>


                                            Follow Us
                                            


























BCIQ / Company Profile


BCIQ Overview   |    
                        Settings   |   
                        Support















Biocentury



Print this                                                    
                        
















                         
                            

    

    

    
                         
                        



                            480 Biomedical Inc.
                        









print preview


export


bookmark


share with colleague





















General Information
                    






 Location

Watertown, Mass.


 Region

New England


 Country

U.S.


 Business Category

Drug delivery, Cardiovascular


 Year Founded

2011


 Website

http://www.480biomedical.com



 Lead Product Status

Pilot (device)






















 Archive Items are loading
                            













 Financial Information
                        






 Financing
                                                Summary







 Financing Details







 Earnings
                                    Summary
                                






 Stocks Annual Chart
                                





















 Pipeline Information
                        






 Pipeline
                                                Summary







 Pipeline Details




















 Deals Information
                        






 Deals
                                                Summary







 Deals Details






















About Biocentury


Company Overview


Management


Editorial & Research




Contact


Contact Us


Advertising & Sponsorship


Career Opportunities




Support


Forgot Password


Customer Service


Reprints


FAQs




Products & Solutions


Products Overview


Publications


Archives


BCIQ


Conferences


eLearning


RSS Feeds




Legal


User Agreement


Terms of Use


Privacy Policy


Your California Privacy Rights


Use of Images

Follow Us
                            











What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

Sign in
Free Trial












© 2017 BioCentury Inc. All Rights Reserved.
     
                        Terms & Conditions
                          |  
                        Privacy Policy











Set Email Alert






dummy













480 Biomedical, Inc. Company Profile




























































BioPortfolio
Biotech, Healthcare and Medical Resources































Advertisement

Topics


All Topics
Biotechnology
Biotech Business
Biotech Products
Cancer
Cardiovascular
Dermatology
Drug Discovery
Endocrinology
Gastroenterology
Immunology
Infectious Diseases
Mental Health
Neurology
Obstetrics
Orthopedics
Public Health
Respiratory
Rheumatology
Urology 
			Track topics on Twitter
Track topics that are important to you




Printed From BioPortfolio.com

480 Biomedical, Inc. Company Profile

13:30 EDT 24th July 2017 | BioPortfolio











      480 Biomedical is using the most sophisticated tools of advanced 
      materials science to create innovative products to treat serious 
      vascular disease and injury.
    


News Articles
[409 Associated News Articles listed on BioPortfolio]
Boston Biomedical Associates creates Boston Biomedical Associates Limited Tel Aviv
Boston Biomedical Associates (BBA), a clinical research and consulting company based in Marlborough, Massachusetts, has announced the opening of an affiliate office, Boston Biomedical Associates Limit...
Proxy Biomedical now operates under Aran Biomedical brand
Ireland-based Proxy Biomedical is rebranding as Aran Biomedical, a new group company and brand created to position itself "in -More- 
Boston Biomedical Promotes Patricia Andrews to CEO
Patricia Andrews has been appointed CEO of Boston Biomedical. Andrews will succeed Chiang Li, who has led the company since he founded the Cambridge, MA-based cancer drug developer in 2007. Andrews ca...
#jobs #lifescience Biomedical Engineer I
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biomedical Engineer I ., Description Hello, We are currently seeking a Biomed...
#jobs #lifescience Matchtech: Biomedical Scientist
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Matchtech: Biomedical Scientist . Negotiable: Matchtech: An opportunity has a...
Paper pumps power portable microfluidics, biomedical devices
(North Carolina State University) Biomedical engineering researchers have developed inexpensive paper pumps that use capillary action to power portable microfluidic devices, opening the door to a rang...
#jobs #lifescience THSTI – JNU PhD Program in Biomedical and Clinical Research
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: THSTI – JNU PhD Program in Biomedical and Clinical Research . THSTI –...
Biomedical Metal Market – Global Forecasts and Opportunity Assessment by Technavio
LONDON–(BUSINESS WIRE)–#MetalsandMinerals–According to the latest market study released by Technavio, the global biomedical metal market is expected to grow at a CAGR of more than 7%...


Drugs and Medications
[4 Associated Drugs and Medications listed on BioPortfolio]
Zorbtive [EMD Serono, Inc.]
Zorbtive [somatropin (rDNA origin) for injection]
Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]
These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...
Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]
These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...
Serostim [EMD Serono, Inc.]
Serostim [somatropin (rDNA origin) for injection]


PubMed Articles
[505 Associated PubMed Articles listed on BioPortfolio]
Real-time three-dimensional digital image correlation for biomedical applications.

Silicon-on-insulator-based complementary metal oxide semiconductor integrated optoelectronic platform for biomedical applications.

Fabrication of PDMS Nanocomposite Materials and Nanostructures for Biomedical Nanosystems.
Recent applications of PDMS nanocomposite materials and nanostructures have dramatically increased in biomedical fields due to optical, mechanical and electrical properties that are controllable by na...
Application of Capillary Electrophoresis with Capacitively Coupled Contactless Conductivity Detection (CE-C(4) D): an update.
Capacitively coupled contactless conductivity detection (C(4) D) has appeared as a powerful technique for the detection of compounds lacking chromogenic or fluorogenic group. Since our last review (Bi...
Fond Memories of our Mentor J. David Hellums, Annals of Biomedical Engineering.



Clinical Trials
[79 Associated Clinical Trials listed on BioPortfolio]
Bigfoot Biomedical Clinical Research Center (CRC) Trial
The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1
      Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical
      Research...
Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care
The aim of this study is the establishment of a warehouse physiological data and biomedical
      signal in intensive care adult patients in acute situations from particular records from the
      Phi...
Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru
This study will evaluate the effectiveness of community-level behavioral and biomedical
      interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually
      transmitte...
Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain
BACKGROUND Shoulder pain is the third most common musculoskeletal disorder observed in
      primary care consultations after low back and neck pain. In the absence of successful
      outcome followi...
Biomedical Shirt-based ECG Monitoring
Cardiovascular diseases (CVD) are associated with high healthcare costs, as well as are a
      leading cause of mortality and hospitalizations. The main challenge for today's researchers
      is to ...


Companies
[575 Associated Companies listed on BioPortfolio]
Quertle, LLC
Quertle 
      is a biomedical search engine focused on delivering informative 
      results to biomedical researchers using advanced linguistic 
      technologies, along with an in-depth und...
Cambridge Biomedical, Inc.
Cambridge 
      Biomedical is a contract research organization (CRO) and diagnostic 
      laboratory providing bioanalytical support to the pharmaceutical, 
      biotechnology, and medical d...
480 Biomedical
480 Biomedical combines deep expertise in materials science with 
      innovative engineering. The StanzaTM bioresorbable SFA 
      scaffold, 480 Biomedicalâs lead product, which entered...
ID Biomedical Corporation
ID Biomedical Corporation is developing products in two distinct new areas of disease control: gene-based diagnostic testing and subunit vaccines. ID Biomedical Corporation products in development tar...
480 Biomedical, Inc.
480 Biomedical is using the most sophisticated tools of advanced 
      materials science to create innovative products to treat serious 
      vascular disease and injury.

More Information about "480 Biomedical, Inc." on BioPortfolio
We have published hundreds of 480 Biomedical, Inc. news stories on BioPortfolio along with dozens of 480 Biomedical, Inc. Clinical Trials and PubMed Articles about 480 Biomedical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 480 Biomedical, Inc. Companies in our database. You can also find out about relevant 480 Biomedical, Inc. Drugs and Medications on this site too.





Quick LinksAdvanced Search |
					Login |
					Subscribe | 
					RSS 

Quick Search






Advertisement


 

Relevant Topic
Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...




Corporate Database Quicklinks
Search Corporate Database
Latest Corporate Records
Biotech Companies by Location
Popular Company Records
Recent Company Searches
Add or Control Your Corporate Profile


Searches Linking to this Company Record


















BioPortfolio Limited

About Us
Contact Us

Social Media

Twitter (200+ Accounts)
Twitter 
Google+ 
LinkedIn 



Publish Content

Publish
Publish Your Press Release
Advertise

Agreements

Agreements
Medical Disclaimer
Privacy



Tools

MyBioPortfolio
RSS

Help

FAQs
Sitemaps
XML Sitemap







			This site complies with the
			HONcode standard for trustworthy health
			information:
Verify here.



		The information provided by BioPortfolio.com is not a substitute for
		professional medical advice, diagnosis or treatment. The BioPortfolio
		site is sponsored BioPortfolio Limited with offices at Stafford House,
		10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you
		are a legal copyright holder or a designated agent for such and you believe a
		post on this website falls outside the boundaries of “Fair Use” and
		legitimately infringes on your or your client's copyright we may be contacted
		concerning copyright matters at: priority@bioportfolio.com.
		
		All rights reserved. All other trademarks recognized. Copyright
		© 1997-2017 BioPortfolio Limited. Site developed by
		Alacrify Ltd.
	
















Biotechnology, Pharmaceutical and Healthcare Company and Supplier Directory/Listing




























































BioPortfolio
Biotech, Healthcare and Medical Resources































Advertisement

Topics


All Topics
Biotechnology
Biotech Business
Biotech Products
Cancer
Cardiovascular
Dermatology
Drug Discovery
Endocrinology
Gastroenterology
Immunology
Infectious Diseases
Mental Health
Neurology
Obstetrics
Orthopedics
Public Health
Respiratory
Rheumatology
Urology 
			Track topics on Twitter
Track topics that are important to you




Printed From BioPortfolio.com

Biotechnology, Pharmaceutical and Healthcare Company and Supplier Directory/Listing

13:30 EDT 24th July 2017 | BioPortfolio











 The BioPortfolio Corporate directory has been designed for three groups of users; the professional executive; the researcher; and the general investor.  The directory lists over 40,000 healthcare, pharmaceutical and biotechnology companies worldwide, involved in research, development, manufacturing and related services.  Companies can be sorted by keyword and each profile provides related press releases and clinical trials - for example Cancer Companies.

 Corporates & NGOs - how to subscribe to ensure your profile is up-to-date with the latest news and products?

 BioPortfolio provides a unique window to the global audience of business professionals, corporate and public researchers, and consumers with an appetite for biotechnology, pharmaceutical and healthcare information.  As a BioCorportate subscriber BioPortfolio will work with you via a dedicated account manager to ensure that we optimize relevant information on your organization published on the site:


  maintain your corporate profile - upto 500 words, images, URLs etc eg Genentech Inc

  promote your products and services - upto 10 entries each with a unique Channel web page eg Vantictumab

  publication of your press releases - upto 20 press releases can be submitted for review and publication - see BioNewsCast

  your RSS feeds - events, press, blogs etc added to our global news service

  social media - weekly tweets to our targeted Twitter accounts


 Contact: pressreleases@bioportfolio.com

Search Companies Only by Keyword: 
Relevance 
Date 




Showing  Companies 1–25 of 52,000+


Monday 24th July 2017
Clear Channel Outdoor Americas (CCOA)
Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) is one of the worldâs 
      largest outdoor advertising companies, with more than 650,000 displays 
      in over 35 countries across five continents, including 43 of the 50 
      largest markets in the United States. Clear Channel Outdoor Holdings 
      offers many types of displays across its global platform to meet the 
      adver...

DNAFit
DNAFit is a UK based genetics company that reports on genetic markers 
      related to fitness and nutrition.

Inland Real Estate Acquisitions, Inc.
Inland Real Estate Acquisitions, Inc. is the purchasing arm for various 
      entities that are a part of The Inland Real Estate Group of Companies, 
      Inc., a group of independent legal entities, some of which may be 
      affiliates, share some common ownership or have been sponsored or 
      managed by Inland Real Estate Investment Corporation or its subsidiaries 
      (collectiv...

Castleman Disease Collaborative Network (CDCN)
CDCN is a global initiative dedicated to accelerating research and 
      treatment for Castleman disease (CD) to improve survival for all 
      patients with CD. The CDCNâs innovative approach first involved building 
      a global community of over 400 physicians and researchers, assembling a 
      scientific advisory board of 28 experts from eight countries, and 
      supporting...

Royal Hawaiian Macadamia Nut
Royal 
      Hawaiian Macadamia Nut is the creator of nutritiously delicious 
      Hawaiian island harvested macadamia nut foods, sold under the Royal 
      Hawaiian Orchardsâ¢ brand. Featuring a better-for-you portfolio of 
      macadamia nut products ranging from chocolate covered, savory roasted, 
      tropical fruit crunch macadamia nuts snacks and macadamia nut milks, 
      Ro...

Pharmacy Times Continuing Education
Pharmacy Times Continuing Educationâ¢ (PTCEâ¢) is a 
      leader in continuing education for retail, health-system, managed care 
      and specialty pharmacists. PTCEâ¢ is accredited by the 
      Accreditation Council for Pharmacy Education as a provider of continuing 
      pharmacy education. Our print, online and live CPE activities are 
      designed to help improve the ...

AHF Pharmacy


Manatt Health
Manatt Health, a division of Manatt, Phelps & Phillips, LLP, is an 
      integrated, multidisciplinary legal, regulatory, advocacy and strategic 
      business advisory healthcare practice. Manatt Healthâs experience spans 
      the major issues re-inventing healthcare, including payment and delivery 
      system transformation; Medicaid coverage, redesign and innovation; 
      he...

Sonora Quest Laboratories
Sonora Quest Laboratories, a joint venture between Banner Health and 
      Quest Diagnostics (NYSE: DGX), is part of the nationâs largest 
      integrated laboratory system with approximately 3,000 employees serving 
      more than 23,000 patients every day throughout Arizona. Sonora Quest 
      Laboratories is the market share leader in clinical laboratory testing 
      in Arizon...

Helix BioMedix, Inc
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of synthetic bioactive peptides. Our patent estate covers...

Crescent Capital Group LP
Crescent Capital Group LP, an SEC-registered investment adviser, is 
      headquartered in Los Angeles with offices in Boston, London and New 
      York. With approximately 65 investment professionals and 120 employees, 
      the firm invests at all levels of the capital structure, with a 
      significant focus on below investment grade credit through strategies 
      that invest in s...

Friday 21st July 2017
HCA Healthcare
Nashville-based HCA Healthcare is one of the nation's leading providers 
      of healthcare services, operating 174 locally managed hospitals and 119 
      freestanding surgery centers in 20 states and the United Kingdom. With 
      its founding in 1968, HCA created a new model for hospital care in the 
      United States, using combined resources to strengthen hospitals, deliver 
     ...

MetroPlus Health Plan
Over 30 years, MetroPlus Health Plan has built a reputation for 
      providing affordable, quality care to residents of Brooklyn, the Bronx, 
      Manhattan and Queens. A health services plan certified under Section 
      4403-a of the New York Public Health Law, MetroPlus is a wholly-owned 
      subsidiary of the New York City Health and Hospitals Corporation (HHC), 
      the nation�...

Tissue Regenix
Tissue Regenix is a leading medical devices company in the field of 
      regenerative medicine. The company's patented decellularisation 
      ('dCELLÂ®') Technology removes DNA and other cellular material from 
      animal and human tissue leaving an acellular tissue scaffold which is 
      not rejected by the patient's body which can then be used to repair 
      diseased or worn o...

PECO Real Estate Partners
PECO 
      Real Estate Partners (PREP), Cincinnati-based owner of The Shoppes 
      at Parma, has incorporated Phillips Edison & Companyâs former 
      development and strategic retail divisions and will focus on the 
      acquisition, repositioning and management of power and lifestyle 
      centers, enclosed malls, mixed-use retail projects and single-tenant 
      developments....

SEPHORA


Thursday 20th July 2017
MedOp Health


Healthcare Group Purchasing Industry Initiative


Ridgemont Equity Partners
Ridgemont Equity Partners is a Charlotte-based private equity firm that 
      specializes in middle market buyout and growth equity investments. Since 
      1993, the principals of Ridgemont have invested over $3 billion in more 
      than 110 companies. The firm focuses on investments of $25 million to 
      $75 million in industries in which it has deep expertise, including 
      bas...

Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. is dedicated to developing and 
      commercializing novel enzyme-based products designed to treat 
      gastrointestinal disorders and rare diseases. The company uses its 
      proprietary technology platform to support a broad pipeline of products, 
      with an initial focus on pancreatic insufficiency, which results in 
      malabsorption common in cysti...

Philogen
Philogen is a Swiss-Italian clinical-stage company engaged in the 
      discovery and development of novel pharmaceutical and biopharmaceutical 
      products. Philogenâs strategy is to deliver bioactive agents, for 
      example cytokines or drugs, to the site of disease using antibodies and 
      other ligands that specifically and efficiently target stromal antigens. 
      This...

Neuland Laboratories Limited (NLL)
Neuland Laboratories Limited, established in 1984, is headquartered in 
      Hyderabad, India, with offices in the U.S. and Japan. Neuland produces 
      quality APIs for customers across 80+ countries in more than 10 diverse 
      therapeutic segments. Along with generic drug products, Neuland offers 
      contract and custom manufacturing services for APIs and advanced 
      intermed...

NeuroVia, Inc.
NeuroVia, Inc. is committed to addressing unmet medical needs in 
      neurological diseases with the primary goal to arrest the onset of 
      devastating neurological deficits associated with X-ALD.

Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc.
Nivalis Therapeutics, Inc. (http://www.nivalis.com) 
      is a pharmaceutical company that has historically been focused on the 
      discovery and development of product candidates for patients with cystic 
      fibrosis, or CF. The Companyâs development candidates selectively target 
      an enzyme known as S-nitrosoglutathione reductase (GSNOR). GSNOR 
      regulates levels of ...

Wednesday 19th July 2017
iProcedures
iProcedures provides software solutions to streamline the perioperative 
      workflow. iProcedures bridges gaps in current enterprise workflow by 
      providing innovative technology solutions, which increase productivity 
      and provide effective, focused, clinical care. iProcedures offers a wide 
      range of specialty-specific products, including a pre-op anesthesia 
      asses...

12345…20>
More From BioPortfolio on ""
Related CompaniesRelated EventsRelated Clinical TrialsRelated PubMed EntriesRelated Medications




Quick LinksAdvanced Search |
					Login |
					Subscribe | 
					RSS 

Quick Search






Advertisement


 

Corporate Database Quicklinks
Search Corporate Database
Latest Corporate Records
Biotech Companies by Location
Popular Company Records
Recent Company Searches
Add or Control Your Corporate Profile


















BioPortfolio Limited

About Us
Contact Us

Social Media

Twitter (200+ Accounts)
Twitter 
Google+ 
LinkedIn 



Publish Content

Publish
Publish Your Press Release
Advertise

Agreements

Agreements
Medical Disclaimer
Privacy



Tools

MyBioPortfolio
RSS

Help

FAQs
Sitemaps
XML Sitemap







			This site complies with the
			HONcode standard for trustworthy health
			information:
Verify here.



		The information provided by BioPortfolio.com is not a substitute for
		professional medical advice, diagnosis or treatment. The BioPortfolio
		site is sponsored BioPortfolio Limited with offices at Stafford House,
		10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you
		are a legal copyright holder or a designated agent for such and you believe a
		post on this website falls outside the boundaries of “Fair Use” and
		legitimately infringes on your or your client's copyright we may be contacted
		concerning copyright matters at: priority@bioportfolio.com.
		
		All rights reserved. All other trademarks recognized. Copyright
		© 1997-2017 BioPortfolio Limited. Site developed by
		Alacrify Ltd.
	
















480 Biomedical Inc 480 Arsenal St Watertown, MA Nonclassified Establishments - MapQuest







































































































    480 Biomedical Inc
  

480 Arsenal St

Watertown
MA
02472




 Reviews



(617) 761-6703
Website

        Menu & Reservations
      



            Make Reservations 




            Order Online
          

            Tickets
          




          Tickets
        


        See Availability
      





      Nearby
    


      Directions
    


    {{::location.tagLine.value.text}}
  



Sponsored Topics








































See a problem?
Let us know!






















Legal






Help























	480 BIOMEDICAL Trademark of 480 Biomedical, Inc.. Serial Number: 85441236 :: Trademarkia Trademarks





























































Apply Online!
Attorneys

Services 

U.S. Trademark Registration Service 
International Trademark Registration Service 
Trademark Office Action Response 
Trademark Statement of Use 
Trademark Renewal 
Trademark Assignment 
Trademark Watch 
Trademark Cease & Desist  
Trademark Comprehensive Search  
Copyright Registration 
Patent Services 
Incorporation Services 
Business Page Creation 
 More Services... 


Help
Contact Us


Login






















Trademark Search 
Trademark Category
Medical Instrument Products
480 BIOMEDICAL










 
Get FREE email alerts













480 BIOMEDICAL  Trademark Information
 480 Biomedical, Inc.
Medical devices for applying biomaterials for coating, pro-healing, sealing, supporting and separating the surfaces of tissues that can act as barriers, depots for drug delivery, and provide structural scaffolding, namely, implantable medical devices to support and prevent the collapse of surrounding tissue, arteries and veins; stents; catheters; stent delivery system and scaffold delivery system for the placement of implantable scaffolds comp...




Perfect for these industries

Medical Instrument Products





Words that describe this mark
medical   devices   applying   biomaterials   coating      prohealing      sealing      supporting   separating   surfaces   tissues   act   barriers      depots   drug   delivery      provide   structural   scaffolding          
                                    




This is a brand page for the 480 BIOMEDICAL trademark by 480 Biomedical, Inc. 
                                in WATERTOWN, MA, 02472.
Write a review about a product or service associated with this 480 BIOMEDICAL trademark.    
                                Or, contact the owner 480 Biomedical, Inc. of the 480 BIOMEDICAL trademark by filing a request to communicate with    
                                the Legal Correspondent for licensing, use, and/or questions related to the 480 BIOMEDICAL trademark.
                           






On Thursday, October 6, 2011,  a U.S. federal trademark registration was filed for 
                        480 BIOMEDICAL by 
                        480 Biomedical, Inc., WATERTOWN, MA  02472.
                        The USPTO has given the 480 BIOMEDICAL 
                        trademark serial  number of  85441236.  
                        The current federal status of this trademark filing is REGISTERED.
                        The correspondent listed for 480 BIOMEDICAL is 
                        
                        
                                            RACHELLE A. DUBOW, ESQ. of 
                                            KACVINSKY DAISAK BLUNI PLLC,  50 Doaks Lane, Marblehead MA 01945 
                                .
                            The 480 BIOMEDICAL trademark is filed in the category of 
                            
                                    Medical Instrument Products
                                . 
                            The description provided to the USPTO for 480 BIOMEDICAL 
                            is Medical devices for applying biomaterials for coating, pro-healing, sealing, supporting and separating the surfaces of tissues that can act as barriers, depots for drug delivery, and provide structural scaffolding, namely, implantable medical devices to support and prevent the collapse of surrounding tissue, arteries and veins; stents; catheters; stent delivery system and scaffold delivery system for the placement of implantable scaffolds comprising artificial materials for maintaining tissue contour; medical guidewires. 
                            





Word mark:
 480 BIOMEDICAL


  Status/Status Date:  


REGISTERED

4/2/2013



  Serial Number:  
85441236


  Filing Date:  
10/6/2011


 Registration Number:  
4313968 


 Registration Date:  
4/2/2013


 Goods and Services: 
Medical devices for applying biomaterials for coating, pro-healing, sealing, supporting and separating the surfaces of tissues that can act as barriers, depots for drug delivery, and provide structural scaffolding, namely, implantable medical devices to support and prevent the collapse of surrounding tissue, arteries and veins; stents; catheters; stent delivery system and scaffold delivery system for the placement of implantable scaffolds comprising artificial materials for maintaining tissue contour; medical guidewires


 Mark Description: 
NOT AVAILABLE


 Type Of Mark: 
TradeMark


 Published For Opposition Date: 
4/17/2012


Last Applicant/Owner:

480 Biomedical, Inc.WATERTOWN, MA  02472
Why is this contact information displayed?  

Why is this contact information displayed? [Close]
The USPTO makes this data available for search by the public so that individuals can locate ownership information for intellectual property, much the same way a county might make real estate property ownership information available.
Since our website is synchronized with the USPTO data, we recommend making any data changes with the USPTO directly. Our website will auto-update when the USPTO data is updated.
You may also contact Trademarkia to make a request for the removal of your personally identifiable information or trademark data.  Such requests must be made in writing and will be subject to verification of ownership.  This policy allows verified trademark owners to specify: (A) that their identifiable information be masked, or (B) that their trademark pages permanently deleted from Trademarkia.com.  
                                                Requests may be made directly to customer.service@trademarkia.com and every effort will be made to honor them within 48 hours. 
Click here for further details.
[Close]




 Mark Drawing Code:  
Standard Character Mark


 Design Search: 


(NO DATA)



Register Type:  
Principal


 Disclaimer:
 ("BIOMEDICAL")


 Correspondent:


RACHELLE A. DUBOW, ESQ.
KACVINSKY DAISAK BLUNI PLLC
50 Doaks Lane
Marblehead MA 01945






 Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.





Classification Information



Primary Class: 
 Class (010) - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.


First Use Anywhere: 
Not provided


First Use In Commerce: 
Not provided





Trademarkia is the largest search engine for U.S. trademarks.  Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.
 LegalForce Network can help you incorporate a business around your 480 BIOMEDICAL trademark in less than 5 minutes.  Trademarkia makes the process easy and convenient, so start now!
 Trademarkia.com is a free search engine of publicly available government records.  Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
Trademark Document Retrieval >>







Trademark - Apply Online!


100% Satisfaction Guarantee protect your valuable brand now.



How it works?
What you get?






1. Legalforce RAPC - #1 U.S. Trademark Filing from 2010 to now.
2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>






1. Top Global IP Attorneys - Credibility and Experience!
2. All processes will be performed in a timely manner. You will be informed periodically about the process.






Keep Track of this Brand.

 Trademark Watch Services
Keep track of how your trademark is being used. Available in the United States and in more than 176 countries. Round-the-clock monitoring. Monthly report on potential infringement.
                                

Watch this Trademark 

Trademark Watch Services read more...

Current Trademark Status:

4/2/2013
REGISTERED


Free Trademark Search:






Correspondent Search:



RACHELLE A. DUBOW, ESQ.


                                             
                                         is a correspondent of 480 BIOMEDICAL trademark. 
                            	    


Current Overall Rating:

 (0 review)
                            
What You Can Do:




Start Your Business



FREE Logo Creator



Add to Favorites



View Documents



FREE Trademark Search



Start Trademark Filing Process



Protect this Mark Internationally



Custom Logo Design $159



Search 480biomedical on popular social networks






                                Trademarkia lets you see how your 
                                personal name, product name, 
                                trademark name or username is being used on any of 530+ new 
                                and popular social networks.  
                                Be the first to reserve your name  and get help stopping others from using it - all in one place!















Trademark Oppose Service


You can request for Extension of Time to Oppose this mark or Oppose it now.



                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password;
                 

                 - If you already have a LegalForce/Trademarkia account, please enter your account's email and password.
                


* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



* 



 Please enter the value




 

  
                             



 







Status Update Alerts

Status Update Alerts are email updates of the latest trademark status change. Please make sure you provide the correct email. 


                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password;
                 

                 - If you already have a LegalForce/Trademarkia account, please enter your account's email and password.
                


* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



* 



 Please enter the value




 

  
                             



 









Review & Rating

Please Rate and Review for 480 BIOMEDICAL 




480 BIOMEDICAL is providing Medical devices for applying biomaterials for coating, pro-healing, sealing, supporting and separating the surfaces of tissues that can act as barriers, depots for drug delivery, and provide structural scaffolding, namely, implantable medical devices to support and prevent the collapse of surrounding tissue, arteries and veins; stents; catheters; stent delivery system and scaffold delivery system for the placement of implantable scaffolds comprising artificial materials for maintaining tissue....
                


                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password to be associated with your review.
                 

                 If you already have a LegalForce/Trademarkia account, please enter your account's email and password before posting your review.
                 


* Please Rate: 


     




* Your Review: 



 Please enter your review.



* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



 

  
                             



 







































480 Biomedical, Inc. - Massachusetts Biotechnology Council









MassBio

Search
Menu









						Search
					



















480 Biomedical, Inc.

Biotechnology
Medical Device


Watertown,
					
						MA


				Arsenal Medical is a medical technology company with an engine to develop localized pro-healing therapies with low-risk, known regulatory pathways to market.

Our expertise in biology, chemistry, materials science, and device engineering creates a bridge from clinical need to biologically-inspired treatment. Our experienced team is creating products first for cardiovascular disease.  We will use our expertise, experience and entrepreneurial culture to expand into multiple therapeutic areas.
			







Contact
617-393-4600
Company Website














480 Biomedical Inc: Company Profile - Bloomberg



































































  









Feedback

























480 biomedical inc
Private Company









Company Profile
Sector: Health Care
Industry: Biotech & Pharma
Sub-Industry: Biotech
480 Biomedical, Inc. provides biopharmaceutical services. The Company design and develops bioresorbable scaffold for treating occlusive diseases in the femoral artery. 480 Biomedical operates in the United States.




Corporate Information
Address:

480 Arsenal Street
Watertown, MA 02472
United States


Phone:
1-617-393-4600


Fax:
1-617-393-4600


Web url:
www.480biomedical.com





Board Members




Partner
Company


Dennis Dougherty
Intersouth Partners








Co-Founder
Company


Carmichael Roberts
Mc10 Inc








Board Members
Company




Robert Langer
Semprus Biosciences Corp


Guido Neels
White Pine Medical LLC


Terrance McGuire
Polaris Venture Partners LP


James Goldstein
North Bridge Venture Partners LP






Show More
























From The Web











Key Executives


Maria Palasis


President/CEO




Amar Kendale


VP: Marketing







Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data








































480 Biomedical












 Skip to main content







Home
About Us
Careers
Contact Us





Our bioresorbable scaffold supports lumen patency during healing while avoiding a permanent implant 



 

 










Bioresorbable Drug Delivery System
480 Biomedical's novel, proprietary drug depot is ideal for localized and controlled delivery of therapeutics.

 













© 2016 480 Biomedical. All rights reserved. 




Web Email






Site Map
Contact Us




























Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.


